0001628280-20-003680.txt : 20200317 0001628280-20-003680.hdr.sgml : 20200317 20200316183944 ACCESSION NUMBER: 0001628280-20-003680 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200316 FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200316 EFFECTIVENESS DATE: 20200317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKWELL MEDICAL, INC. CENTRAL INDEX KEY: 0001041024 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 383317208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23661 FILM NUMBER: 20718678 BUSINESS ADDRESS: STREET 1: 411 HACKENSACK AVE., SUITE 501 CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 2489609009 MAIL ADDRESS: STREET 1: 411 HACKENSACK AVE., SUITE 501 CITY: HACKENSACK STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20120530 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL, INC. DATE OF NAME CHANGE: 20120525 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19970722 NT 10-K 1 rmti-20191231x10nt.htm NT 10-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
SEC File Number: 000-23661
CUSIP Number: 774374102
 
 
 
 
(Check one):    
 
x  Form 10-K     ☐  Form 20-F     ☐  Form 11-K     ☐  Form 10-Q
☐  Form 10-D     ☐  Form N-SAR    
 
 
 
 
For Period Ended: December 31, 2019
 
 
 
 
☐  Transition Report on Form 10-K
 
 
 
 
☐  Transition Report on Form 10-Q
 
 
 
 
For the Transition Period Ended:     
 
 
 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
PART I — REGISTRANT INFORMATION
Rockwell Medical Inc.
Full Name of Registrant
 
Former Name if Applicable

411 Hackensack Avenue, Suite 501
Address of Principal Executive Office (Street and Number)
Hackensack, NJ 07601
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 




 
 
 
 
 
x   
 
(a)
 
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
(b)
 
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c)
 
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, or N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Registrant’s Annual Report on Form 10-K for the period ended December 31, 2019 cannot be filed within the prescribed time period without unreasonable effort or expense because of a delay in the completion of the Registrant’s financial statements resulting from its entry into a Loan and Security Agreement on the date hereof, which needed to be reflected in the financial statements.

PART IV — OTHER INFORMATION
 
(1
)
 
Name and telephone number of person to contact in regard to this notification
 
 
Angus Smith
 
(248)
 
432-1997
 
 
(Name)
 
(Area Code)
 
(Telephone Number)
(2
)
 
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ☐ No
(3
)
 
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?    ☒  Yes    x  No

 
Rockwell Medical Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
Date 
 
March 16, 2020
 
 
 
By 
 
 
 
/s/ Angus Smith
 
 
 
 
 
 
 
 
 
 
Angus Smith
 
 
 
 
 
 
 
 
 
 
Chief Financial Officer (Principal Financial Officer)